In September 2026, U.S. regulators cleared a robotic helper meant to keep a flexible colonoscope steadier for looking and treating throughout the colon.

Two clocks matter: the FDA decision date on the device record was 3 September 2026; the company announcement landed on 16 September 2026. Clearance here means “substantially equivalent” to a predicate pathway (Class II) — not a trophy that the new system beat every manual exam everywhere.

Early first-in-human company reports (CARE 1, n=50, single center) claimed strong feasibility signals — treat those percentages as company-reported, not a large randomized contest against every manual practice.

This chapter is news context for the capability class. Naming a brand is not the invention. Steadier control for a thorough look remains the open job.